Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
Primary Purpose
Hip Fracture, Delirium
Status
Terminated
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Zolpidem
Sponsored by
About this trial
This is an interventional prevention trial for Hip Fracture focused on measuring Hip fracture, delirium, sleep disturbance, hypnotic
Eligibility Criteria
Inclusion Criteria: Primary hip fracture, no substance abuse, no regular opioid, corticosteroid or benzodiazepine therapy, hepatic insufficiency, myastenia gravis, allergies to drug components Exclusion Criteria: Severe respiratory insufficiency
Sites / Locations
- Hvidovre University Hospital
Outcomes
Primary Outcome Measures
Incidence and severity of postoperative delirium
Secondary Outcome Measures
Sleep quality
mobilization
loss of functional ability
length of stay
sedation
nocturnal nursing events
Full Information
NCT ID
NCT00286936
First Posted
February 3, 2006
Last Updated
August 29, 2011
Sponsor
Hvidovre University Hospital
Collaborators
IMK Fonden
1. Study Identification
Unique Protocol Identification Number
NCT00286936
Brief Title
Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
Official Title
Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
Study Type
Interventional
2. Study Status
Record Verification Date
September 2006
Overall Recruitment Status
Terminated
Why Stopped
Slow inclusion resulting in premature termination due to logistics
Study Start Date
February 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Hvidovre University Hospital
Collaborators
IMK Fonden
4. Oversight
5. Study Description
Brief Summary
To examine the influence of regular hypnotic therapy on the incidence of delirium after hip fracture surgery
Detailed Description
Delirium is prevalent after hip fracture surgery. Delirium has been linked to postoperative sleep disturbances. Zolpidem is a non-benzodiazepine hypnotic that preserves REM sleep. The present study investigates the incidence of delirium in hip fracture patients randomized to Zolpidem treatment 5 mg vs placebo in the perioperative phase.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Fracture, Delirium
Keywords
Hip fracture, delirium, sleep disturbance, hypnotic
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
96 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Zolpidem
Primary Outcome Measure Information:
Title
Incidence and severity of postoperative delirium
Secondary Outcome Measure Information:
Title
Sleep quality
Title
mobilization
Title
loss of functional ability
Title
length of stay
Title
sedation
Title
nocturnal nursing events
10. Eligibility
Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Primary hip fracture, no substance abuse, no regular opioid, corticosteroid or benzodiazepine therapy, hepatic insufficiency, myastenia gravis, allergies to drug components
Exclusion Criteria:
Severe respiratory insufficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolai B Foss, MD
Organizational Affiliation
Hvidovre University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Hvidovre University Hospital
City
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo
We'll reach out to this number within 24 hrs